Real-world reporting rates of administration-site reactions with on-demand treatment of hereditary angioedema attacksTachdjian R, Savic S, Fridman M, Frade JP, Fasehun M, Audhya PK
Allergy and Asthma Proceedings
Understanding Why Hereditary Angioedema Patients Often Do Not Carry Their On-Demand Treatment with ThemGeng B, van Kooten S, Heckmann M, Danese S, Goga L, Radojicic C
ACAAI 2023
Treatment Patterns Among Individuals with Hereditary Angioedema in the United StatesTachdjian R, Chang R, DerSarkissian M, Cribbs KA, Lahue BJ, Czado S, Desai V
ACAAI 2023
Anxiety Associated with On-Demand Treatment of HAE Attacks May Result in Suboptimal Attack ManagementManning M, van Kooten S, Heckmann M, Danese S, Goga L, Ogbogu PU
ACAAI 2023
In Their Own Words – Patient Descriptions of the Earliest Recognition of HAE Attack OnsetManning ME, Burnette AF, van Kooten S, Heckmann M, Danese S, Goga L, Guilarte M
HAEA National Summit 2023
Recognizing the Importance of Early On-Demand Treatment in the HAE Attack JourneyJones DH, Ogbogu P, van Kooten S, Heckmann M, Danese S, Goga L, Magerl M
HAEA National Summit 2023
Understanding the complex decision-making associated with on-demand treatment of hereditary angioedema (HAE) attacksGrumach A, van Kooten S, Heckmann M, Danese S, Goga L, Garcez T
EAACI 2023
Remaining burden of hereditary angioedema (HAE) attacks despite modern long-term prophylaxisBetschel S, van Kooten S, Heckmann M, Danese S, Caballero T
EAACI 2023
Results From a Randomized, Double-Blind, Placebo-Controlled, Phase 1 Trial Evaluating Sebetralstat Pharmacokinetics, Pharmacodynamics, and Safety/Tolerability in Healthy Japanese, Chinese, and White AdultsHide M, Iverson M, Jhee S, Hansen E, Duckworth EJ, Hampton SL, Yoon E, Honda D
EAACI 2023
Patients delay treating hereditary angioedema (HAE) attacks with currently available, injectable, on-demand therapies: associated with on-demand treatment of hereditary angioedema (HAE) attacksValerieva A, van Kooten S, Heckmann M, Danese S, Goga L, Longhurst H
EAACI 2023
